Indi Molecular
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6160 Bristol Pkwy Ste 200, Culver City, ...Phone Number
(310) 215-4410Website
www.indimolecular.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Indi Molecular
Indi Molecular specializes in developing synthetic small molecule targeted oncology therapeutics aimed at treating ovarian cancer and KRAS G12D expressing pancreatic cancers. Utilizing a proprietary synthetic protein chemistry platform known as Protein Catalyzed Capture (PCC), the company creates small peptide replacements for traditional antibody-based therapies. Their products are characterized by high specificity, low binding affinities, and stability, allowing for rapid synthesis and effective therapeutic delivery. Indi Molecular's innovations are designed for clients in the oncology sector seeking advanced treatment options.Explore more
Indi Molecular Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Indi Molecular your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Indi Molecular is spiking on competitors!
Earning: See what the market has to say on Indi Molecular recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Indi Molecular
Funding: Get notified immidiatlly once Indi Molecular has new funding data
Click to see if Indi Molecular had a recent Job posting/layoffs
Check if Indi Molecular has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Indi Molecular launches new products
Indi Molecular, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Indi Molecular as Masked Content
Find 3 more new buyers
Compare Similar Companies to Indi Molecular
Compare insights from companies similar to Indi Molecular, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Indi Molecular is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Indi Molecular is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Indi Molecular.
Indi Molecular financials insights
Gather financial insights about Indi Molecular, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Angel/Seed
$1.5M
Angel/Seed
$300K
2017
Private Equity
$4.5M
Series A
$11.5M
Indi Molecular Tech Stack
A closer look at the technologies used by Indi Molecular
Indi Molecular News & Media
Indi Molecular Appoints Dr. Michael T. Klimas as Senior VP Strategy & Technical Business Development
CULVER CITY, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Indi Molecular, an emerging life sciences company, announced today that it has appointed Michael T. Klimas Ph.D. as senior vice president of strategy and technical business development. Dr. Klimas is a well-known life sciences executive who most recently served at Merck Research Laboratories’ executive director translational biomarker immuno-oncology and cardiometabolic lead. Indi Molecular is developing a novel, synthetic class of binders w
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Indi Molecular
Sign Up For FreeTo access detailed company insights
Indi Molecular specializes in developing synthetic small molecule targeted oncology therapeutics aimed at treating ovarian cancer and KRAS G12D expressing pancreatic cancers. Utilizing a proprietary synthetic protein chemistry platform known as Protein Catalyzed Capture (PCC), the company creates small peptide replacements for traditional antibody-... Read More
